Low-dose aspirin and surgical site infection in patients with heart failure: A retrospective cohort study
Published
May 19, 2024
Paper ID
PAP-000266
Status
Published
DOI
10.65712/tmj.test000524
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on low-dose aspirin. Methods: The primary outcome was surgical site infection, assessed blind to allocation. Results: 2729 participants were included (median age 41 years). Serious adverse events were rare and similar between groups. Conclusion: Strengths include the sample size and blinded outcome assessment.
References
1. Lindqvist K, Volkov Y, et al. Point-of-care ultrasound and surgical site infection. Crit Care Med. 2024;276(1):631-1090.
2. Rossi P, Ibrahim N, et al. Home-based cardiac rehabilitation and 30-day readmission. N Engl J Med. 2013;35(1):517-1470.
3. Herrera T, Herrera N, et al. Prone positioning and length of stay. Diabetes Care. 2020;155(8):851-1017.
4. Ibrahim C, Moreau Z, et al. Continuous glucose monitoring and falls. Eur Heart J. 2009;46(8):345-1093.
5. Ibrahim I, Rossi R, et al. Nurse-led discharge planning and patient satisfaction. Eur Heart J. 2020;317(9):362-1338.
6. Volkov K, Zhang I, et al. Continuous glucose monitoring and emergency department revisits. Lancet. 2011;80(2):820-954.
7. Dubois E, Dubois I, et al. An antibiotic stewardship programme and glycaemic control. N Engl J Med. 2020;337(8):628-1772.
8. Schmidt E, Kim C, et al. Continuous glucose monitoring and health-related quality of life. N Engl J Med. 2020;326(1):674-1191.
9. Farouk G, Novak H, et al. Tranexamic acid and health-related quality of life. Crit Care Med. 2008;115(8):437-1424.
Introduction
Practice around low-dose aspirin varies widely between centres.
surgical site infection remains a leading cause of avoidable harm among patients with heart failure. Practice around low-dose aspirin varies widely between centres. The cost of surgical site infection to health systems is substantial.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. Eligible participants were patients with heart failure.
Analyses were adjusted for age, sex and baseline severity. Eligible participants were patients with heart failure. We conducted a retrospective cohort study across 14 centres between 2014 and 2025. Missing data were handled with multiple imputation.
Results
Effects were consistent across prespecified subgroups. 1358 participants were included (median age 51 years).
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Female | 141 | 11 | 15.4 | 0.47 |
| Centre A | 674 | 99 | 29.4 | 0.55 |
| Male | 759 | 54 | 13.6 | 0.53 |
Values are n (%) unless stated otherwise.

Shown for patients with heart failure; error bars are 95% confidence intervals.
4149 participants were included (median age 68 years). Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.67 (95% CI 0.27 to 0.93).
Discussion
Residual confounding cannot be excluded. Future work should test low-dose aspirin in a pragmatic multicentre trial. These findings suggest that low-dose aspirin is associated with better surgical site infection in patients with heart failure. Implementation will depend on staffing, cost and local protocols.
Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols. These findings suggest that low-dose aspirin is associated with better surgical site infection in patients with heart failure.
These findings suggest that low-dose aspirin is associated with better surgical site infection in patients with heart failure. Strengths include the sample size and blinded outcome assessment.
These findings suggest that low-dose aspirin is associated with better surgical site infection in patients with heart failure. Strengths include the sample size and blinded outcome assessment. Future work should test low-dose aspirin in a pragmatic multicentre trial. Residual confounding cannot be excluded.
These findings suggest that low-dose aspirin is associated with better surgical site infection in patients with heart failure. Strengths include the sample size and blinded outcome assessment.
Conclusions
Low-dose aspirin is a reasonable option for patients with heart failure to improve surgical site infection.
Appendices
The statistical analysis plan is in the online supplement.